Cannabis Bioscience International Holdings, Inc.
Data quality: 100%
CBIH
OTC
Services
Engineering & Management Services
$0.00
▲
$0.00
(25.00%)
Mkt Cap: 5.81 M
Price
$0.00
Mkt Cap
5.81 M
Day Range
$0.00 — $0.00
52-Week Range
$0.00 — $0.00
Volume
12,000
Open $0.00
50D / 200D Avg
$0.00
25.00% above
50D / 200D Avg
$0.00
0.00% above
Quick Summary
Key Takeaways
Negative free cash flow of -408,419.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)21.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-333.39%
Op. Margin-245.25%
Safety
Debt / Equity
N/A
Current Ratio0.02
Interest Coverage-2.92
Valuation
PE (TTM)
-8.65
Below sector avg (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.7 | -1.2 |
| P/B | — | 1.4 |
| ROE % | — | -15.7 |
| Net Margin % | -333.4 | -18.3 |
| Rev Growth 5Y % | — | 4.2 |
| D/E | — | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.77% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 201,601.0 | Net Income (TTM) | -672,127.0 |
| ROE | N/A | ROA | -3272.84% |
| Gross Margin | 75.01% | Operating Margin | -245.25% |
| Net Margin | -333.39% | Free Cash Flow (TTM) | -408,419.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.02 |
| Interest Coverage | -2.92 | Asset Turnover | 9.82 |
| Working Capital | -1.11 M | Tangible Book Value | -1.36 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.65 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 28.84 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7.03% | ||
| Market Cap | 5.81 M | Enterprise Value | 6.10 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.00 | Revenue / Share | 0.00 |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 60.77% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 303,022.0 | 248,841.0 |
| Net Income | -548,820.0 | -651,345.0 |
| EPS (Diluted) | 0.00 | 0.00 |
| Gross Profit | 262,916.0 | 203,242.0 |
| Operating Income | -421,365.0 | -486,140.0 |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | 136,262.0 | 154,206.0 |
| Income Tax | — | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 31,880.0 | 57,162.0 |
| Total Liabilities | 1.20 M | 1.14 M |
| Shareholders' Equity | -1.16 M | -1.08 M |
| Total Debt | 286,187.0 | 256,415.0 |
| Cash & Equivalents | — | — |
| Current Assets | 29,085.0 | 21,492.0 |
| Current Liabilities | 945,963.0 | 881,908.0 |
{"event":"ticker_viewed","properties":{"ticker":"CBIH","listing_kind":"stock","pathname":"/stocks/cbih","exchange":"OTC","country":"US"}}